
Currently out of the existing stock ratings of Reni Benjamin, 287 are a BUY (88.58%), 37 are a HOLD (11.42%).
Analyst Reni Benjamin, has had 47.22% of price targets met with an average potential upside of 47.18%, reached in 267 days on average. Previously, Reni Benjamin worked at RAYMOND JAMES, HC WAINWRIGHT.
Reni Benjamin has documented 593 price targets and ratings displayed on 45 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYME, Zymeworks.
Analyst best performing recommendations are on IOVA (IOVANCE BIOTHERAPEUTICS).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) on 3/3/2026. The price target of $5 was fulfilled within 3 days with a profit of $1.25 (33.33%), with a performance score of 111.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2022
$14
$10.63 (315.43%)
$15
3 months 18 days ago
(30-Jul-2026)
0/25 (0%)
$9.99 (249.13%)
Buy Since 20-Apr-2021
$8
$4.63 (137.39%)
$8
5 months 14 days ago
(03-Jun-2026)
1/17 (5.88%)
$3.8 (90.48%)
174
Hold Since 14-Feb-2022
$12
$8.63 (256.08%)
$13
7 months 9 days ago
(08-Apr-2026)
0/10 (0%)
$7.02 (140.96%)
Hold Since 18-Mar-2026
$7
$3.63 (107.72%)
$11
7 months 30 days ago
(18-Mar-2026)
0/4 (0%)
$2.3 (48.94%)
Buy Since 11-Jun-2020
$36
$32.63 (968.25%)
7 months 30 days ago
(18-Mar-2026)
3/10 (30%)
$31.3 (665.96%)
192
Which stock is Reni Benjamin most bullish on?
Which stock is Reni Benjamin most reserved on?